(Q80013636)
Statements
Aliskiren, a novel oral renin inhibitor, provides dose-dependent efficacy and placebo-like tolerability in Japanese patients with hypertension (English)
Toshio Kushiro
Hiroshige Itakura
Yoshihisa Abo
Hiromi Gotou
Shinji Terao
Deborah L Keefe
1 December 2006